QUANTIFY RESEARCH is a global partner to the pharmaceutical industry in close partnership with academia, patients, public institutions & clinical experts.

Real-world evidence & analytics
Quantify is the leading provider of RWE generated from the world-renouned Nordic data. Through our local presence, expert staff, institutional know-how and more than 10 years’ hands-on experience with the Nordic data, we offer an unparalleled ability to advise and execute Nordic RWE studies with local and global applications. Quantify has a successful track record of advising clients on securing Nordic ethical approval, data access, and optimizing analysis for commercial or regulatory purposes. We also offer RWE services in the EU, UK, and US.

Modelling, Access & Strategy
Quantify is a global provider of health economic evidence and a specialist provider of Nordic market access services including economic models, reimbursement dossiers, and strategic advice. Our experience and expertise ensures an optimized, streamlined market access process across the Nordics. For non-technical stakeholders, Quantify also develops value tools and visualisation dashboards to enhance communication. Our expert staff include ex-payers, ex-pharma,  modelling experts, and experienced project managers.

Evidence review & synthesis
Quantify has long standing experience reviewing, interpreting and communicating evidence as part of targeted or systematic literature reviews (SLR). Our team ensures these activities are done systematically, with a focus on usability, to support knowledge management and commercialization activities. QUANTIFY is experienced in summarizing the results of this work through meta-analyses and narrative reviews. Our team consists of 50% PhDs and integrated AI solutions to provide our clients with the very best services.

Press

15Sep 2021

Abstract and poster co-authored by Quantify to be presented at ESMO21

An abstract and poster co-authored by Quantify’s Hanna Fues Wahl, Rosa Lauppe, and Mathias Lilja will be presented at the ESMO – European Society for Medical Oncology Congress 2021, taking place 16-21 September. For this abstract, called “Palbociclib dose patterns in Swedish patients with metastatic breast cancer: Evidence from the SIRI study”, the Quantify team has provided RWE results on […]
10Sep 2021

Helena Skröder joins Quantify!

Today we proudly introduce our newest Lead Analyst Helena Skröder who joined our Stockholm team last week.

Helena has a PhD in Medicine with a focus in nutritional toxicology from Karolinska institutet. She also has experience in working with some of the Swedish national registers to study health effects of occupational and environmental factors during pregnancy and early-life. Helena is excited to join Quantify Research where she will develop […]

8Sep 2021

Global Status Report on the public health response to dementia

With an ageing population, the prevalence of #dementia and the social and economic burden in the world is rising. Quantify’s Oskar Frisell has co-authored chapter 3 in the latest Global Status Report on the public health response to dementia, in which the global costs of dementia have been estimated. Read the full report at the World Health Organization (WHO) homepage: […]